HomeProductsBioactive CompoundsEpigeneticsSirtuinRencofilstat
Chemical structure of CAS 1383420-08-3

Rencofilstat

CAS No.1383420-08-3
MDL No.N/A
MFC67H122N12O13
MW1303.80
InChI KeyKBARHGHBFILILC-NGIJKBHDSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.1383420-08-3
Product NameRencofilstat

Associated Conditions

hepatocellular carcinoma·non-alcoholic fatty liver disease
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

A Pan-Cyclophilin Inhibitor, CRV431, Decreases Fibrosis and Tumor Development in Chronic Liver Disease Models.

The Journal of pharmacology and experimental therapeutics • Vol. 371, Issue 2 • 2019
PMID: 31406003PMC: PMC6815936DOI: 10.1124/jpet.119.261099

Development, Characterization, and Pharmacokinetic Evaluation of a CRV431 Loaded Self-Microemulsifying Drug Delivery System.

Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques • Vol. 21, Issue 1s • 2018
PMID: 30472978DOI: 10.18433/jpps30245

In Vitro Phase I Metabolism of CRV431, a Novel Oral Drug Candidate for Chronic Hepatitis B.

Pharmaceutics • Vol. 9, Issue 4 • 2017
PMID: 29120380PMC: PMC5750657DOI: 10.3390/pharmaceutics9040051

The Novel Cyclophilin Inhibitor CPI-431-32 Concurrently Blocks HCV and HIV-1 Infections via a Similar Mechanism of Action.

PloS one • Vol. 10, Issue 8 • 2015
PMID: 26263487PMC: PMC4532424DOI: 10.1371/journal.pone.0134707

Documentation

Similar Products